Weronika Kopyt

Weronika Kopyt

Auto-generated profile, based on publicly available information

Weronika Kopyt

Student Scientific Society of Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, 20-093 Lublin, Poland

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 January 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
MLMaria Leśniak
Maria Leśniak
JLJustyna Lipniarska
Justyna Lipniarska
PMPatrycja Majka
Patrycja Majka
WKWeronika Kopyt
Weronika Kopyt
MLMonika Lejman
Monika Lejman
Joanna ZawitkowskaJoanna Zawitkowska
Joanna Zawitkowska
Toll-like receptors (TLR) belong to the pattern recognition receptors (PRR). TLR7 and the closely correlated TLR8 affiliate with toll-like receptors family, are located in endosomes. They recognize single-stranded ribonucleic acid (RNA) molecules and synthetic deoxyribonucleic acid (DNA)/RNA analogs—oligoribonucleotides. TLRs are primarily expressed in hematopoietic cells. There is compiling evidence implying that TLRs also direct the formation of blood cellular components and make a contribution to the pathogenesis of certain hematopoietic malignancies. The latest research shows a positive effect of therapy with TRL agonists on the course of hemato-oncological diseases. Ligands impact activation of antigen-presenting cells which results in production of cytokines, transfer of mentioned cells to the lymphoid tissue and co-stimulatory surface molecules expression required for T-cell activation. Toll-like receptor agonists have already been used in oncology especially in the treatment of dermatological neoplastic lesions. The usage of these substances in the treatment of solid tumors is being investigated. The present review discusses the direct and indirect influence that TLR7/8 agonists, such as imiquimod, imidazoquinolines and resiquimod have on neoplastic cells and their promising role as adjuvants in anticancer vaccines.

7 September 2024 in Pathogens
Verified
Journal Article
Open access
PDF file
NZNatalia Zaj
Natalia Zaj
WKWeronika Kopyt
Weronika Kopyt
EKEmilia Kamizela
Emilia Kamizela
JZJulia Zarychta
Julia Zarychta
AKAdrian Kowalczyk
Adrian Kowalczyk
Joanna ZawitkowskaJoanna Zawitkowska
Joanna Zawitkowska
Fungal infections constitute a significant challenge and continue to be a predominant cause of treatment failure in pediatric leukemia cases. Despite the implementation of antifungal prophylaxis, these infections contribute to approximately 20% of cases in children undergoing treatment for acute lymphoblastic leukemia (ALL). The aim of this study is to highlight the diagnostic and therapeutic challenges associated with invasive fungal infections (IFIs). We also present a review of the epidemiology, risk factors, treatment, and a clinical presentation of IFI in patients with ALL. This case report details the clinical course of confirmed Candida albicans (C. albicans) and Aspergillus spp. infections during the consolidation phase of ALL treatment in a 5-year-old pediatric patient. This male patient did not experience any complications until Day 28 of protocol II. Then, the patient’s condition deteriorated. Blood culture detected the growth of C. albicans. Despite the implementation of targeted therapy, the boy’s condition did not show improvement. The appearance of respiratory symptoms necessitated a computed tomography (CT) of the chest, which revealed multiple nodular densities atypical for C. albicans etiology. In spite of ongoing antifungal treatment, the lesions depicted in the CT scans showed no regression. A lung biopsy ultimately identified Aspergillus species as the source of the infection. Overcoming fungal infections poses a considerable challenge; therefore, an accurate diagnosis and the prompt initiation of targeted therapy are crucial in managing these infections in patients with leukemia.

7 March 2026 in Quality in Sport
Verified
Journal Article
Open access
PDF file
NKNatalia Kaczmarczyk
Natalia Kaczmarczyk
ZGZofia Gołąbek
Zofia Gołąbek
JKJana Kozłowska
Jana Kozłowska
SSSimone Szymczyk
Simone Szymczyk
HKHanna Kaczuba
Hanna Kaczuba
WKWeronika Kopyt
Weronika Kopyt
Background. Endometriosis is a chronic, estrogen-dependent inflammatory disease characterized by the presence of endometrial-like tissue outside the uterus, leading to severe pelvic pain, dysmenorrhea, dyspareunia, and reduced quality of life. Despite multiple therapeutic options, effective pain control remains challenging, particularly in patients with severe or recurrent disease. Aim. This study aimed to synthesize current evidence on hormonal and non-hormonal pain-management strategies for severe symptoms in endometriosis. Material and methods. A systematic literature review was conducted using PubMed, ScienceDirect, ResearchGate, and Google Scholar. Randomized controlled trials, cohort studies, and case-control studies published between 2022 and 2025 were included. Studies evaluating pain outcomes using validated pain assessment tools were eligible. Data were extracted regarding intervention type, patient characteristics, follow-up duration, pain outcomes, and risk of bias. Results. Hormonal therapies, including progestogen-based treatments, combined estrogen–progestogen regimens, and gonadotropin-suppressing agents, demonstrated effectiveness in reducing dysmenorrhea and inflammation however outcome varies by formulation, dose, and patient hormonal responsiveness.Non-hormonal approaches, such as anti-inflammatory analgesics, neuromodulatory agents, physical therapies, and multidisciplinary care, provided additional symptom relief, although responses varied considerably among patients. Treatment effectiveness was influenced by reproductive plans, tolerability, contraindications, and long-term safety. Conclusions. Hormonal therapies remain the most effective first-line option for pain reduction in patients with moderate-to-severe endometriosis who are not seeking pregnancy. Individualized, multimodal treatment strategies are essential to address symptom variability and optimize long-term outcomes.

10 April 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
JLJakub Lech
Jakub Lech
AMAnna Marcinkowska
Anna Marcinkowska
JNJulia Nowosielska
Julia Nowosielska
KSKarol Stobiński
Karol Stobiński
APAleksandra Płusa
Aleksandra Płusa
KLKatarzyna Latalska
Katarzyna Latalska
IntroductionPolycystic ovary syndrome (PCOS) is a complex endocrine disorder characterized by reproductive, metabolic, and inflammatory disturbances. Increasing evidence suggests that gut microbiota plays a significant role in the regulation of metabolic and neuroendocrine pathways involved in PCOS. AimThe aim of this review was to summarize current knowledge on the gut-brain-ovary axis in PCOS, with particular focus on the contribution of gut microbiota dysbiosis to metabolic inflammation and reproductive dysfunction. Material and methodsA narrative review of the literature was conducted using PubMed/MEDLINE, Scopus, and Web of Science databases. Peer-reviewed articles published in English up to March 2024 were analyzed. Studies addressing associations, underlying mechanisms, and therapeutic interventions linking gut microbiota with metabolic, inflammatory, neuroendocrine, and reproductive features of PCOS were included. ResultsAvailable evidence indicates that women with PCOS exhibit significant alterations in gut microbiota composition, including reduced microbial diversity, decreased abundance of short-chain fatty acid-producing bacteria, and increased prevalence of pro-inflammatory taxa. These changes are associated with insulin resistance, impaired intestinal barrier function, metabolic endotoxemia, chronic low-grade inflammation, hyperandrogenism, and disturbances in hypothalamic-pituitary-ovarian signaling. ConclusionsGut microbiota dysbiosis appears to play an important integrative role in the pathophysiology of PCOS by linking metabolic inflammation with neuroendocrine and ovarian dysfunction. The gut-brain-ovary axis represents a promising conceptual framework and therapeutic target; however, further well-designed longitudinal and mechanistic studies are required.

4 April 2026 in Quality in Sport
Verified
Journal Article
Open access
UZUrszula Zaluska
Urszula Zaluska
SSSimone Szymczyk
Simone Szymczyk
PBPatryk Barczuk
Patryk Barczuk
NPNatalia Pluta
Natalia Pluta
KSKarol Stobiński
Karol Stobiński
SJSabina Jóźwiak
Sabina Jóźwiak
The rapid development of wearable technologies has significantly influenced contemporary team sports by enabling advanced athlete monitoring and supporting data-driven training management. The aim of this systematic review was to evaluate the role of wearable technologies in team sports, with particular emphasis on training load monitoring, athlete performance analysis, and injury prevention. A comprehensive literature search was conducted using PubMed, Scopus, and Web of Science, and studies were selected according to predefined inclusion and exclusion criteria. The analyzed literature indicates that wearable technologies, such as global positioning systems (GPS), inertial measurement units (IMU), accelerometers, and heart rate monitors, are widely used to assess both external and internal training load. These systems enable continuous data collection on movement patterns, physiological responses, and biomechanical demands during training and competition. As a result, they support workload evaluation, facilitate individualized training programs, and enhance evidence-based decision-making. Wearable technologies also contribute to injury prevention by enabling monitoring of cumulative load and sudden changes in training intensity, which may indicate increased injury risk. However, limitations remain, including issues related to measurement validity, inter-device variability, and challenges in data interpretation. In conclusion, wearable technologies represent valuable tools for improving athlete monitoring, optimizing training processes, and supporting injury prevention in team sports. Their effectiveness depends on both device accuracy and appropriate data interpretation. Further research is needed to standardize their application across different sports and performance levels.

24 September 2025 in Polish Annals of Medicine
Verified
Journal Article
Open access
WKWeronika Kopyt
Weronika Kopyt
NZNatalia Zaj
Natalia Zaj
EWEwelina Wawryk-Gawda
Ewelina Wawryk-Gawda
VOVioletta Opoka-Winiarska
Violetta Opoka-Winiarska
Introduction: Diseases caused by Corynebacterium spp. are rare in humans. The atypical clinical presentation of the infection may cause diagnostic difficulties. Aim: In this case report, we present the medical history of a 3-year-old patient admitted to the hospital with symptoms characteristic of Kawasaki disease. Case study: The child presented with a persistent fever, a red throat, conjunctival hyperaemia, enlargement of the submandibular and cervical nodes, maculopapular rash on the trunk. In the laboratory tests the significant elevation of inflammatory markers, an increased plasma concentration of N-terminal pro B-type natriuretic peptide (NT-proBNP) were observed. Additionally, the girl was not fully vaccinated. Despite the administration of antibiotic therapy, the patient's general condition deteriorated. Irregularities in heart rhythm were also noticed. For these reasons, the patient was transferred to a tertiary reference hospital. Although the criteria for Kawasaki disease were met, due to the persistent coating on both tonsils and pharynx, further diagnostics were deemed necessary. A microbiological examination revealed the cultivation of coryneform bacteria. Appropriate antibiotic treatment led to the improvement of the girl's condition. Results and discussion: The described case indicates two important pediatric problems. The first one concerns the diagnosis of fevers with atypical symptoms related to rare infections. The second one concerns the similarity of symptoms of infections and Kawasaki disease. Conclusions: Attention should be paid to the atypical course of infection, which may mimic other diseases. In the differential diagnosis, it is worth considering opportunistic infections, rare microorganisms.